Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.28 USD | -3.39% | +6.29% | -24.25% |
May. 06 | Omega Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 16 | Omega Therapeutics CFO Joshua Reed to Depart | MT |
Chart calendar Omega Therapeutics, Inc.
Upcoming events on Omega Therapeutics, Inc.
Past events on Omega Therapeutics, Inc.
2024-05-08 12:00 pm | American Society of Gene & Cell Therapy Meeting - Abstract Number: 697 |
2024-05-06 07:00 am | Q1 2024 Earnings Release |
2024-04-08 12:00 pm | American Association for Cancer Research Meeting - Abstract Number: 2417 |
2024-04-08 12:00 pm | American Association for Cancer Research Meeting - Abstract Number: 1726 |
2024-03-28 09:15 am | Q4 2023 Earnings Release |
2024-01-11 12:45 pm | JPMorgan Healthcare Conference |
2023-12-06 09:30 am | H.C. Wainwright Precision Oncology Virtual Conference |
2023-11-29 12:00 pm | Piper Sandler Healthcare Conference |
2023-11-14 07:30 am | Jefferies London Healthcare Conference |
2023-11-12 01:00 pm | AASLD Liver Meeting - Poster number: 3444-A |
2023-11-11 01:00 pm | AASLD Liver Meeting - Poster number: 2621-A |
2023-11-09 07:00 am | Q3 2023 Earnings Release |
2023-10-31 11:00 am | International mRNA Health Conference - Poster #: 79 |
2023-10-14 12:30 pm | AACR-NCI-EORTC International Conference - Poster number: C104 |
2023-10-03 11:30 am | Chardan Genetic Medicines Conference |
2023-09-27 08:00 am | Jefferies Cell & Genetic Medicine Summit |
2023-09-26 08:00 am | OTX Phase 1/2 Trial Results Call |
2023-08-03 04:00 pm | Q2 2023 Earnings Release |
2023-06-14 05:40 pm | Goldman Sachs Global Healthcare Conference |
2023-06-08 08:30 am | Jefferies Healthcare Conference |
Annual results
Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,14 0,00 - | 2,07 1,58 30.91% | 3,09 2,53 22.34% | 4,20 |
EBITDA Million USD | Released Forecast Spread | 0,00 | -64,6 -62,7 -3.16% | -101 -95,8 -5.67% | 0,00 -104 - | -91,7 |
EBIT Million USD | Released Forecast Spread | 0,00 | -66,0 -67,4 2.04% | -103 -102 -0.73% | -100 -107 5.95% | -85,3 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -68,3 -71,4 4.34% | -103 -100 -2.21% | -97,4 -103 5.03% | -78,1 |
Net income Million USD | Released Forecast Spread | -29,4 | -68,3 -71,6 4.62% | -103 -102 -1.15% | -97,4 -103 5.03% | -78,1 |
EPS USD | Released Forecast Spread | -7,56 | -3,05 -2,69 -13.59% | -2,14 -2,12 -0.75% | -1,80 -1,86 3.1% | -1,24 |
Announcement Date | 09/07/21 | 10/03/22 | 01/03/23 | 28/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,27 0,00 - | 0,48 0,05 824.27% | 0,60 0,10 487.94% | 0,74 0,26 185.44% | 0,52 0,31 66.45% | 0,76 0,43 76.51% | 0,83 0,38 116.78% | 0,99 0,53 86.6% | 2,36 1,16 102.7% | 0,53 | 0,53 | 0,53 | 0,50 | 0,43 |
EBIT Million USD | Released Forecast Spread | -20,0 -26,9 25.72% | -25,9 -24,7 -4.75% | -26,0 -29,6 12.16% | -31,0 -30,2 -2.46% | -25,8 -32,8 21.36% | -30,8 -29,0 -6.47% | -22,9 -31,6 27.49% | -20,7 -27,0 23.43% | -20,5 -20,7 1.15% | -21,3 | -21,3 | -21,9 | -14,0 | -15,5 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -20,2 -24,8 18.55% | -25,9 -22,9 -13.33% | -25,8 -28,3 8.79% | -30,8 -28,6 -7.75% | -25,3 -31,1 18.64% | -29,7 -27,9 -6.58% | -22,2 -30,7 27.58% | -20,2 -25,4 20.33% | -20,1 -19,8 -1.64% | -20,3 | -19,8 | -19,7 | -14,0 | -15,5 |
Net income Million USD | Released Forecast Spread | -20,2 -27,0 25.33% | -25,9 -25,6 -1.05% | -25,8 -30,0 13.88% | -30,8 -29,7 -3.94% | -25,3 -32,6 22.41% | -29,7 -27,9 -6.58% | -22,2 -30,7 27.58% | -20,2 -25,4 20.33% | -20,1 -19,8 -1.64% | -20,3 | -19,8 | -19,7 | -14,0 | -15,5 |
EPS USD | Released Forecast Spread | -0,42 -0,57 25.88% | -0,54 -0,54 -0.62% | -0,54 -0,62 12.2% | -0,64 -0,62 -2.89% | -0,50 -0,63 20.13% | -0,54 -0,50 -7.57% | -0,40 -0,55 26.74% | -0,37 -0,45 17.32% | -0,36 -0,36 0.92% | -0,35 | -0,31 | -0,29 | -0,24 | -0,24 |
Announcement Date | 04/05/22 | 04/08/22 | 08/11/22 | 01/03/23 | 04/05/23 | 03/08/23 | 09/11/23 | 28/03/24 | 06/05/24 | - | - | - | - | - |
2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
2024-05-20 | ALVOTECH: Q1 2024 Earnings Release |
2024-05-21 | CUREVAC N.V.: Q1 2024 Earnings Release (Projected) |
2024-05-21 | EXSCIENTIA PLC: Q1 2024 Earnings Release (Projected) |
2024-05-21 | EVOTEC SE: Q1 2024 Earnings Release |
2024-06-30 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
Past sector events for Omega Therapeutics, Inc.
Today | REPLIMUNE GROUP, INC.: Q4 2024 Earnings Release (Projected) |
2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
2024-05-14 07:30 am | ABSCI CORPORATION: Q1 2024 Earnings Release |
2024-05-13 | BELITE BIO, INC: Q1 2024 Earnings Release |
2024-05-13 | POLARIS GROUP: Q1 2024 Earnings Release |
2024-05-13 04:30 pm | AEROVATE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-13 07:00 am | APOGEE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-12 07:00 pm | PRAXIS PRECISION MEDICINES, INC.: Q1 2024 Earnings Release |
2024-05-13 06:30 am | FORTREA HOLDINGS INC.: Q1 2024 Earnings Release |
2024-05-13 04:10 pm | CENTESSA PHARMACEUTICALS PLC: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- OMGA Stock
- Calendar Omega Therapeutics, Inc.